Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.

NCT00267917 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive
Asthma

Interventions

DEVICE: Berodual Respimat
DEVICE: Berodual HFA-MDI

Sponsor

Boehringer Ingelheim